Regeneron PharmaceuticalsREGN 
$1,162.002.04%24h
2.04%24h
Global rank111
Market cap$124.48B
Change 7d-0.00%
YTD Performance32.97%
SP500 benchmarkOutperform
P/E0
P/S9.49
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
Regeneron Pharmaceuticals (REGN) Net Assets
REGN Net Assets in 2023: $25.97B
As of 23 Nov 2024, Regeneron Pharmaceuticals net assets is $25.97B, an increase of 14.60% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Regeneron Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Regeneron Pharmaceuticals Net Assets History from 2018 to 2024
-
Value:-
REGN Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $25.97B | 14.60% |
| 2022 | $22.66B | 20.75% |
| 2021 | $18.77B | 70.23% |
| 2020 | $11.03B | -0.58% |
| 2019 | $11.09B | 111.55% |
| 2018 | $5.24B | - |
View the Top Net Assets Companies
